- Abstract
- Keywords
- Introduction
- Chemistry of BD
- Antineoplastic effects of BD in human malignancies
- Anti-metastatic effects of BD
- Potential anti-inflammatory effects of BD
- Pharmacokinetics, toxicity and metabolism
- Clinical application of BD
- Conclusion and future directions
- Abbreviations
- Declarations
- References
-
Citing Article List
The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Cannabis-based medicinal products (CBMPs) for the treatment of Long COVID symptoms: current and potential applications”.No. Publication Date Citing Article 1 2024 Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, Carol Croser, David John Nutt, Elizabeth Iveson. Authors' response to letter ‘On the use of open‐label studies for the evaluation of cannabis‐based products for the treatment of long‐COVID’, British Journal of Clinical Pharmacology. 2024; bcp.16174. https://doi.org/10.1111/bcp.16174 2 2024 Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, Carol Croser, David John Nutt, Elizabeth Iveson. Feasibility of a cannabidiol‐dominant cannabis‐based medicinal product for the treatment of long COVID symptoms: A single‐arm open‐label feasibility trial, British Journal of Clinical Pharmacology. 2024; 90: 1081. https://doi.org/10.1111/bcp.15988 -
